J Mark Alles

Affiliations

  • Director at Syros Pharmaceuticals Inc. (SYRS), 2023-09-19
  • Director at Biomarin Pharmaceutical Inc (BMRN), 2023-05-24
  • Director at Turning Point Therapeutics Inc. (TPTX), 2022-08-17
  • Ceo, Chairman Of Board at Celgene Corp (CELG), 2019-11-22
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BMRN $86.75 3,625 $314,468.75 10,905 2022-10-31 Filing
TPTX $81.34 2,000 $162,680.00 2,000 2021-06-21 Filing
SYRS $8.86 10,000 $88,590.00 10,000 2020-05-13 Filing
CELG $82.60 1,208 $99,784.42 187,316 2018-05-09 Filing
CELG $91.90 3,260 $299,594.00 178,904 2018-02-08 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
CELG $120.68 117,099 $14,131,156.02 56,902 2015-02-06 Filing
CELG $146.47 5,000 $732,335.00 14,946 2013-08-02 Filing
CELG $147.01 96,406 $14,172,646.06 4,946 2013-07-31 Filing